13GD Coverage: Heartland Advisors Inc Just Opened Huge Digirad Corp Position

13GD Coverage: Heartland Advisors Inc Just Opened Huge Digirad Corp Position

The New Heartland Advisors Inc Holding in Digirad Corp

Heartland Advisors Inc filed with the SEC SC 13G/A form for Digirad Corp. The form can be accessed here: 000089271216001926. As reported in Heartland Advisors Inc’s form, the filler as of late owns 4.6% or 900,000 shares of the Health Care–company.

Digirad Corp stake is a new one for the for this institutional investor and it was filed because of activity on September 30, 2016. We feel this shows Heartland Advisors Inc’s positive view for the stock. For a institutional investor managing $6.06 billion in assets and having 51+ active experts, we at Financialmagazine have no doubt the buy is a bullish signal.

Digirad Corp Institutional Sentiment

Latest Security and Exchange filings show 45 investors own Digirad Corp. The institutional ownership in Q3 2015 is low, at 76.23% of the outstanding shares. This is increased by 4629953 the total institutional shares. 14918644 were the shares owned by these institutional investors. In total 2 funds opened new Digirad Corp stakes, 11 increased stakes. There were 6 that closed positions and 11 reduced them.

Punch & Associates Investment Management Inc is an institutional investor bullish on Digirad Corp, owning 1200788 shares as of Q3 2015 for 0.61% of its portfolio. Perkins Capital Management Inc owns 139500 shares or 0.58% of its portfolio. WY Cannell Capital Llc have 1.30% of their stock portfolio for 928040 shares. Further, Jw Asset Management Llc reported stake worth 0.15% of its US stock portfolio. The NY Krensavage Asset Management Llc owns 457699 shares. Digirad Corp is 0.62% of the manager’s US portfolio.

Business Profile

Digirad Corporation is a provider of diagnostic solutions. The Company’s business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services. It also provides cardiac event monitoring services to physician practices, hospitals and imaging centers through its Diagnostic Services business segment. The Company sells solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications, as well as provides service on the products it sells through its Diagnostic Imaging business segment. Diagnostic Services also offers remote cardiac event monitoring services, which include provision of a monitor, remote monitoring by registered nurses and monitoring support for its patients and physician customers. Its nuclear cameras feature detectors based on solid-state technology. Its cameras are used in hospitals, imaging centers, physician offices, and by mobile service providers.

SEC Form 13G is required when the filer owns between (5% and 20%) of a company and plans to hold it only as a passive investor. In case the filler intend to exert control and the stake’s exceeds 20%, then 13D Form must be filed. These filings can NOT be a precursor to “change of control” events such as hostile takeovers, company breakups or others.

Heartland Advisors Inc website.

Insitutional Activity: The institutional sentiment increased to 1.35 in 2016 Q2. Its up 0.53, from 0.82 in 2016Q1. The ratio is positive, as 5 funds sold all Digirad Corporation shares owned while 15 reduced positions. 11 funds bought stakes while 16 increased positions. They now own 10.84 million shares or 2.53% less from 11.12 million shares in 2016Q1.

The New York-based Art Ltd has invested 0% in Digirad Corporation (NASDAQ:DRAD). Perritt last reported 0.03% of its portfolio in the stock. Wealthtrust reported 50 shares or 0% of all its holdings. Axa last reported 0% of its portfolio in the stock. Hillsdale Inv Mgmt holds 0.11% of its portfolio in Digirad Corporation (NASDAQ:DRAD) for 75,280 shares. Zurcher Kantonalbank (Zurich Cantonalbank) last reported 8,800 shares in the company. The New York-based National Bank Of New York Mellon has invested 0% in Digirad Corporation (NASDAQ:DRAD). Moreover, Dimensional Fund Advisors Ltd Partnership has 0% invested in Digirad Corporation (NASDAQ:DRAD) for 1.00 million shares. Walleye Trading Ltd accumulated 0% or 5,500 shares. Glacier Peak Ltd Liability holds 123,816 shares or 0.68% of its portfolio. Blackrock Fund Advisors has invested 0% of its portfolio in Digirad Corporation (NASDAQ:DRAD). Vanguard Grp has 1.12 million shares for 0% of their US portfolio. The Utah-based Albion Fincl Group Ut has invested 0.01% in Digirad Corporation (NASDAQ:DRAD). Wells Fargo And Mn has 1 shares for 0% of their US portfolio. First New York Lc Ny holds 0% or 6,000 shares in its portfolio.

Insider Transactions: Since May 27, 2016, the stock had 8 insider buys, and 2 selling transactions for $291,210 net activity. Eberwein Jeffrey E. had bought 5,625 shares worth $28,145. Molchan Matthew G. had sold 5,833 shares worth $29,222 on Friday, May 27. $122,498 worth of Digirad Corporation (NASDAQ:DRAD) shares were sold by Lott Virgil.

Analysts await Digirad Corporation (NASDAQ:DRAD) to report earnings on November, 4. They expect $0.08 EPS, 0.00% or $0.00 from last year’s $0.08 per share. DRAD’s profit will be $1.57 million for 15.88 P/E if the $0.08 EPS becomes a reality. After $0.09 actual EPS reported by Digirad Corporation for the previous quarter, Wall Street now forecasts -11.11% negative EPS growth.

About 30,290 shares traded hands. Digirad Corporation (NASDAQ:DRAD) has declined 1.35% since March 2, 2016 and is downtrending. It has underperformed by 9.61% the S&P500.

Digirad Corporation is a provider of diagnostic solutions. The company has a market cap of $99.41 million. The Company’s business is organized into two divisions: Diagnostic Services and Diagnostic Imaging. It has a 3.11 P/E ratio. The Firm provides in-office nuclear cardiology and ultrasound imaging services.

More notable recent Digirad Corporation (NASDAQ:DRAD) news were published by: Globenewswire.com which released: “Digirad Corporation Announces Agreement to Acquire DMS Health Technologies for …” on October 14, 2015, also Marketwatch.com with their article: “Digirad Corp. NASDAQ: DRAD” published on December 21, 2009, Seekingalpha.com published: “Digirad Corporation’s (DRAD) CEO Matt Molchan on Q2 2016 Results – Earnings …” on July 31, 2016. More interesting news about Digirad Corporation (NASDAQ:DRAD) were released by: Nasdaq.com and their article: “Digirad Corporation (DRAD) Ex-Dividend Date Scheduled for August 15, 2016” published on August 12, 2016 as well as Globenewswire.com‘s news article titled: “Digirad Corporation to Release 2016 First Quarter Financial Results On April …” with publication date: April 22, 2016.

According to Zacks Investment Research, “DIGIRAD CORPORATION provides diagnostic nuclear and ultrasound imaging systems and services to physicians’ offices, hospitals and other medical services providers for cardiac, vascular, and general imaging applications. Digirad’s Cardius XPO line of nuclear imaging cameras use patented solid-state technology and unique multi head design for superior performance and advanced features for sharper digital images, faster processing, compact size, lighter weight for portability, ability to handle patients up to 500 pounds, and improved patient comfort compared to standard nuclear cameras. Digirad’s 2020tc general-purpose nuclear imager has a small footprint and may also be configured for fixed or mobile use to supplement primary imaging. Digirad’s installed base of equipment exceeds 550 systems; in addition, a mobile fleet of 164 nuclear and ultrasound imaging systems is being used in 22 states and the District of Columbia, primarily in the eastern, midwestern and southwestern United States.”

DRAD Company Profile

Digirad Corporation, incorporated on January 2, 1997, is a well-known provider of diagnostic solutions. The Company’s business is organized into two divisions: Diagnostic Services and Diagnostic Imaging. The Firm provides in-office nuclear cardiology and ultrasound imaging services. The Firm also provides cardiac event monitoring services to physician practices, hospitals and imaging centers through its Diagnostic Services business segment. The Firm sells solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications, as well as provides service on the products it sells through its Diagnostic Imaging business segment.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment